AUSTIN, Texas, April 26, 2017 /PRNewswire/ — Luminex Corporation (NASDAQ: LMNX) announced today that management will present at the Deutsche Bank 42nd Annual Health Care Conference on Wednesday, May 3, 2017 at 10:00am ET in Boston, Massachusetts.
The investor presentation will be webcast live and may be accessed at Luminex Corporation’s website at http://www.luminexcorp.com. Simply log on to the web at the address above, go to the Company section and access the Investor Relations link. Please go to the website at least 15 minutes prior to the event to register, download and install any necessary audio/video software. If you are unable to participate during the live webcast, the presentation will be archived for six months on the website using the ‘replay’ link.
ABOUT LUMINEX CORPORATION
At Luminex, our mission is to empower labs to obtain reliable, timely, and actionable answers, ultimately advancing health. We offer a wide range of solutions applicable in diverse markets including clinical diagnostics, pharmaceutical drug discovery, biomedical research, genomic and proteomic research, biodefense research, and food safety. We accelerate reliable answers while simplifying complexity and deliver certainty with a seamless experience. To learn more about Luminex, please visit us at www.luminexcorp.com.
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/luminex-corporation-to-present-at-the-deutsche-bank-42nd-annual-health-care-conference-300445467.html
SOURCE Luminex Corporation
http://investor.luminexcorp.com/phoenix.zhtml?c=79403&p=RssLanding&cat=news&id=2265813